Research Studies

Use the links in the box on the left for information on each of the studies being conducted by the PASA Consortium.

The exact number and type of studies to be conducted will depend on the quantity and quality of applications received and if the optional funding is provided. The types of studies correspond to the Consortium’s three Aims.

The PASA Consortium currently has two studies under development and three active studies. 

 

Type of Study

Population

Focus

Goal

Aim 1

Discovery Studies

Animal Models

Alcohol Dependence

Screen potential compounds for therapeutic potential in animal models for ASUD and PTSD

Aim 2

Human Proof of Concept Studies

Human Subjects

Compounds from discovery studies or similar preclinical testing

Take the best candidate compounds from discovery to test for medical safety and for indicators of potential effectiveness

Aim 3

Phase II Safety and Preliminary Efficacy Clinical Trials

Human Subjects

 

 

 

 

Potential medication combinations in patients with ASUD and concurrent PTSD with or without the chronic effects of mild TBI

Identify potential medications or medication combinations for ASUD with PTSD;

Determine if there is enough evidence of efficacy to support moving forward with Phase III clinical trials



Current Participating Study Sites

The PASA Consortium currently has two studies under development and three active studies.